-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HwT2xPkNCVX9i6qHoxR3P9WLaw3WqEnRagpYAiKOlgK27NXz24vCd8N3rr93XCuf
 sKHsBOW6qUc0G3YqkHqxDA==

<SEC-DOCUMENT>0000904454-04-000092.txt : 20040212
<SEC-HEADER>0000904454-04-000092.hdr.sgml : 20040212
<ACCEPTANCE-DATETIME>20040212152841
ACCESSION NUMBER:		0000904454-04-000092
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20040212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALLOS THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001097264
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				541655029
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-60251
		FILM NUMBER:		04591253

	BUSINESS ADDRESS:	
		STREET 1:		11080 CIRCLEPOINT ROAD
		STREET 2:		SUITE 200
		CITY:			WESTMINSTER
		STATE:			CO
		ZIP:			80020
		BUSINESS PHONE:		3034266262

	MAIL ADDRESS:	
		STREET 1:		7000 NORTH BROADWAY
		STREET 2:		SUITE 400
		CITY:			DENVER
		STATE:			CO
		ZIP:			80221

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		7325242454
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>s13ga_021104.txt
<DESCRIPTION>SCHEDULE 13G,  AMENDMENT NO. 1
<TEXT>
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                -----------------

                                  SCHEDULE 13G
                                 (Rule 13d-102)

             INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
           TO RULES 13d-1(b),(c) AND (d) AND AMENDMENTS THERETO FILED
                            PURSUANT TO RULE 13d-2(b)

                               (Amendment No. 2)1


                            ALLOS THERAPEUTICS, INC.
 ------------------------------------------------------------------------------
                                (Name of Issuer)



                                  Common Stock
 ------------------------------------------------------------------------------
                         (Title of Class of Securities)



                                   019777 10 1
 ------------------------------------------------------------------------------
                                 (CUSIP Number)


                                December 31, 2003
  -----------------------------------------------------------------------------
             (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which
this Schedule is filed:

         [ ] Rule 13d-1(b)

         [ ] Rule 13d-1(c)

         [X] Rule 13d-1(d)



- ------------------
         1The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.



<page>

CUSIP No. 019777 10 1                                         Page 2 of 5 Pages


________________________________
1.   NAMES OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

           Johnson & Johnson
           22-1024240
________________________________
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
               (a) [  ]
               (b) [  ]
________________________________
3.   SEC USE ONLY
________________________________
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

               New Jersey
________________________________
   NUMBER OF                        5.   SOLE VOTING POWER
    SHARES
 BENEFICIALLY                                 -0-
   OWNED BY
      EACH                          6.   SHARED VOTING POWER
   REPORTING
    PERSON                                    -0-
     WITH

                                    7.   SOLE DISPOSITIVE POWER

                                              -0-

                                    8.   SHARED DISPOSITIVE POWER

                                              -0-

________________________________
9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                  -0-

________________________________
10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

                  [  ]
________________________________
11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

                  -0-
________________________________
12.      TYPE OF REPORTING PERSON

                  CO
________________________________

<page>

CUSIP No. 019777 10 1                                         Page 3 of 5 Pages

________________________________
1.  NAMES OF REPORTING PERSONS
     I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

      Johnson & Johnson Development Corporation
      22-2007137
________________________________
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
                  (a) [  ]
                  (b) [  ]
________________________________
3.   SEC USE ONLY
________________________________
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

         New Jersey
________________________________
   NUMBER OF                        5.   SOLE VOTING POWER
    SHARES
 BENEFICIALLY                                 -0-
   OWNED BY
      EACH                          6.   SHARED VOTING POWER
   REPORTING
    PERSON                                    -0-
     WITH

                                    7.   SOLE DISPOSITIVE POWER

                                              -0-

                                    8.   SHARED DISPOSITIVE POWER

                                              -0-

________________________________
9.       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

                  -0-

________________________________
10.      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

                  [  ]
________________________________
11.      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

                  -0-
________________________________
12.      TYPE OF REPORTING PERSON

                  CO
________________________________

<page>

CUSIP No. 019777 10 1                                         Page 4 of 5 Pages


                Amendment No. 2 to Schedule 13G (Final Amendment)
                -------------------------------------------------

          Reference is hereby made to the statement on Schedule 13G filed with
the Securities and Exchange Commission on February 14, 2001 and Amendment No. 1
thereto filed on February 4, 2003 (as so amended, the "Schedule 13G"). Terms
defined in the Schedule 13G are used herein as so defined.

          The following items of the Schedule 13G are hereby amended and
restated as follows:

ITEM 4.     OWNERSHIP.

            (a) Amount Beneficially Owned:

            J&J: -0-
            JJDC: -0-

            (b) Percent of Class:

            J&J: -0-
            JJDC: -0-

            (c) Number of shares as to which such person has:

            (i) sole power to vote or to direct the vote: -0-

            (ii) shared power to vote or to direct the vote:

            J&J: -0-
            JJDC: -0-

            (iii) sole power to dispose or to direct the disposition of:  -0-

            (iv) shared power to dispose or to direct the disposition of:

            J&J: -0-
            JJDC: -0-

ITEM 5.     OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.

          If this statement is being filed to report the fact that as of the
date hereof the reporting persons have ceased to be the beneficial owners of
more than five percent of the Common Stock, check the following [X].




<page>

CUSIP No. 019777 10 1                                         Page 5 of 5 Pages


                                    SIGNATURE

          After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

                                     JOHNSON & JOHNSON


                                     By     /s/ Michael H. Ullman
                                     --------------------------------------
                                     Name: Michael H. Ullmann
                                     Title: Secretary

Dated: February 11, 2004

                                     JOHNSON & JOHNSON DEVELOPMENT CORPORATION


                                     By    /s/ Eric B. Jung
                                     --------------------------------------
                                     Name: Eric B. Jung
                                     Title: Secretary

Dated: February 11, 2004

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
